← Research library

Cortexin effectiveness in circulatory encephalopathy

Comparison in people · 1999

What was studied
76 patients with dyscirculatory encephalopathy: 45 adjunctive Cortexin, 31 standard care
Main finding
Reports neurological and cognitive changes with nasal-electrophoresis delivery alongside standard care.

Rehabilitation efficiency · 22.7% improvement reported with add-on Cortexin · The abstract does not define the denominator or scoring formula for this percentage

Reported findings and study design

76 patients with stage I–II dyscirculatory encephalopathy: standard care 31 versus standard care plus nasal-electrophoresis Cortexin 45.

Population or model 76 patients with dyscirculatory encephalopathy: 45 adjunctive Cortexin, 31 standard care

Results · Previously retrieved indexed abstract; numerical statements checked against the saved source text
MeasureResultComparison, timing and statistics
Rehabilitation efficiency22.7% improvement reported with add-on CortexinThe abstract does not define the denominator or scoring formula for this percentage

Values describe this study and its comparison. Unreported effect sizes and missing denominators have not been inferred.

Source for these results ↗ · Reviewed 2026-10-29

Study limitations and source details

Study limitations

  • The abstract does not establish randomization or blinding.
  • Delivery route and clinical population differ from other Cortexin reports.

Source details

Indexed abstract and citation checked via Europe PMC / PubMed; full methods and risk of bias not appraised.

Sources checked

Citation

Human comparative studyEnglish abstract

Khavinson VKh, Morozov VG, Rybnikov VIu, Zakutskiĭ NG. Cortexin effectiveness in circulatory encephalopathy Klin Med (Mosk) 77(4):42-45. PMID 10356917

Study source ↗ · Bibliography entry · Link to this summary

Related compounds

Editorial policy and evidence standards